Global nanoparticle analysis market value will increase considerably in the future due to the introduction of advanced technologies in the healthcare sector. The approval rate of various novel medicines is rising at a notable rate because the incidence of chronic infections & diseases is also increasing every year. The FDA approved 53 new drugs in 2020. This was the second-highest figure in over 20 years.
Global nanoparticle analysis market size will exceed USD 4 billion by 2028. This disturbing trend has prompted pharma & biopharma companies to increase their research & development efforts to develop newer and more effective medicines. It will accelerate the adoption of nanoparticle analysis technologies to determine whether the nanosized particles used for examination can carry the required drugs and carefully deliver them during treatment.
According to the WHO, noncommunicable diseases (NCDs) claim 41 million lives every year, which is equal to 71% of all deaths across the world. The report also states that cardiovascular disease (CVD) accounts for the most NCD deaths, killing 17.9 million people each year.
Request for a sample copy of this research report @ https://www.gminsights.com/request-sample/detail/3955
Role of nanoparticle analysis in targeted therapies:
Nanotechnology is popularly used in therapies like gene editing to manipulate or make changes in the genome sequence of a patient to find out possible disease-causing mutations. For this purpose, nanoparticle analysis is important because the nanosized particles will be used as drug carrying vehicles in targeted therapies.
There are many advantages of opting for nanoparticles over the traditional drug delivery systems, such as high specificity, stability, and great drug carrying capacity. They also facilitate controlled release of a chemical, which can further enhance patient outcomes.
For example, researchers at the Tel Aviv University, Israel were successful in showing the efficacy of a drug delivery system based on lipid nanoparticles. The research showed that these nanoparticles can use RNA to successfully overcome resistance to immunotherapy as well as chemotherapy in cancer treatments. The success of this study is expected to open new opportunities for developing personalized treatments against cancer.
Government initiatives will fuel nanotechnology research:
The field of nanotechnology is expanding at a robust rate due to its widespread applications in drug development processes. With the incidence of acute health disorders rising across the world, the demand for effective medicines has grown tremendously.
Governments are realizing the potential of nanotechnology in drug development & delivery systems and are introducing favorable initiatives in this regard. For instance, the U.S. government, in October 2021, launched the 2021 National Nanotechnology Initiative (NNI) Strategic Plan to support the research and development efforts in the field of nanotechnology.
Browse report summary @ https://www.gminsights.com/industry-analysis/nanoparticle-analysis-market
Europe nanoparticle analysis market grows at a notable pace:
Europe nanoparticle analysis market potential will be strengthened by the large-scale research activities taking place across medical institutes. For instance, in March 2021, the European Union unveiled the PHOENIX project, which is funded by the region’s Horizon 2020 Framework Programme. The aim of this scheme is to provide services for the development and commercialization of nano-pharmaceuticals from the lab to the market. These drugs will be made available to startups, SMEs, research laboratories and other interested parties.
Global nanoparticle analysis market will expand at a substantial rate due to the rising awareness about the benefits of nanotechnology. Companies, such as Horiba Ltd., Agilent Technologies, Inc., Shimadzu Corporation, Thermo Fisher Scientific, Hitachi, Ltd., and Bruker Corporation, among others, are the leading developers of nanoparticle analysis technologies. The pioneers have opportunities to focus toward catering to key applications across public and private research initiatives, along with major biopharma demands.
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: [email protected]
Web: https://www.gminsights.com/